Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31078599 | 0.79 | — | — | |
| SCHEMBL4175653 | 0.79 | — | — | |
| SCHEMBL14019694 | 0.77 | CYP3A4 (0.35) | CYP1A2 | |
| SCHEMBL13688396 | 0.77 | — | — | |
| SCHEMBL13688355 | 0.74 | CYP3A4 (0.37) | CYP1A2 | |
| SCHEMBL13688370 | 0.73 | ALDH1A1 (0.38) | — | |
| SCHEMBL4004361 | 0.73 | TSHR (0.36) | CYP1A2 | |
| SCHEMBL13688401 | 0.73 | CYP3A4 (0.31) | CYP1A2 | |
| SCHEMBL13688398 | 0.73 | — | — | |
| SCHEMBL13688397 | 0.73 | KMT2A (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3278786-B1 | DENTAL MATERIALS ON THE BASIS OF VINYLCYCLOPROPANE DERIVATIVES CONTAINING URETHANE GROUPS | IVOCLAR VIVADENT AG (LI) | 2019-01-23 | — | — | EP | claimed |
| US-7585901-B2 | Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials | IVOCLAR VIVADENT AG (LI) | 2009-09-08 | — | — | US | disclosed |
| US-7585901-B2 | Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials | IVOCLAR VIVADENT AG (LI) | 2009-09-08 | — | — | US | disclosed |
| US-7585901-B2 | Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials | IVOCLAR VIVADENT AG (LI) | 2009-09-08 | — | — | US | disclosed |
| US-20080261118-A1 | OPTICAL RECORDING COMPOSITION AND HOLOGRAPHIC RECORDING MEDIUM | FUJIFILM CORPORATION (JP) | 2008-10-23 | — | — | US | disclosed |
| US-7365222-B2 | 1,1-Disubstituted 2-vinylcyclopropanes; free radical polymerizable monomers | IVOCLAR VIVADENT AG (LI) | 2008-04-29 | — | — | US | disclosed |
| US-7365222-B2 | 1,1-Disubstituted 2-vinylcyclopropanes; free radical polymerizable monomers | IVOCLAR VIVADENT AG (LI) | 2008-04-29 | — | — | US | disclosed |
| US-7365222-B2 | 1,1-Disubstituted 2-vinylcyclopropanes; free radical polymerizable monomers | IVOCLAR VIVADENT AG (LI) | 2008-04-29 | — | — | US | disclosed |
| US-20070232719-A1 | POLYMERIZABLE BICYCLIC CYCLOPROPANE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF DENTAL MATERIALS | IVOCLAR VIVADENT AG (LI) | 2007-10-04 | — | — | US | disclosed |
| US-20070232719-A1 | POLYMERIZABLE BICYCLIC CYCLOPROPANE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF DENTAL MATERIALS | IVOCLAR VIVADENT AG (LI) | 2007-10-04 | — | — | US | disclosed |
| US-20070232719-A1 | POLYMERIZABLE BICYCLIC CYCLOPROPANE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF DENTAL MATERIALS | IVOCLAR VIVADENT AG (LI) | 2007-10-04 | — | — | US | disclosed |
| EP-1413569-B1 | Bicyclic cyclopropane derivatives capable of polymerisation and their use in the preparation of dental materials | IVOCLAR VIVADENT AG (LI) | 2006-12-13 | — | — | EP | disclosed |
| EP-1413569-A1 | Bicyclic cyclopropane derivatives capable of polymerisation and their use in the preparation of dental materials | Ivoclar Vivadent AG (LI) | 2004-04-28 | — | — | EP | disclosed |
| US-20040077882-A1 | Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials | IVOCLAR VIVADENT AG (LI) | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232719-A1 | POLYMERIZABLE BICYCLIC CYCLOPROPANE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF DENTAL MATERIALS | CBR1, CYP8B1, OXER1 | CYP1A2 89/4885 |
| US-20040077882-A1 | Polymerizable bicyclic cyclopropane derivatives and their use for the preparation of dental materials | SCO2, CBR1, CORO1C | CYP1A2 132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.